Synthesis and characterization of 111in - DTPA - N-TIMP-2: A radiopharmaceutical for imaging matrix metalloproteinase expression

Bioconjugate Chemistry

Volumn 12, Issue 6, 2001, Pages 964-971

  Giersing, B K ^a   Rae, M T ^a   Carballidobrea, M ^a   Williamson, R A ^a   Blower, P J ^a  

^a UNIVERSITY OF KENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS; ELECTROSPRAY IONIZATION; ENZYME INHIBITION; IMAGE PROCESSING; MASS SPECTROMETRY; TUMORS;

DIETHYLENETRIAMINE PENTA-ACETIC ACIDS; EXTRACELLULAR MATRICES; IMAGING MATRICES; METALLOPROTEINASES; OVEREXPRESSIONS; SYNTHESIS AND CHARACTERIZATIONS; TISSUE INHIBITOR OF METALLOPROTEINASES; TISSUE INHIBITOR OF METALLOPROTEINASES-2; TUMOR IMAGING;

AMINO ACIDS;

DIAGNOSTIC AGENT; ENZYME INHIBITOR; INDIUM; MATRIX METALLOPROTEINASE; PENTETIC ACID; RADIOPHARMACEUTICAL AGENT; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR PROTEIN;

ARTICLE; CHEMISTRY; DRUG DESIGN; DRUG STABILITY; HUMAN; METABOLISM; PEPTIDE MAPPING; PROTEIN BINDING; SYNTHESIS;

DRUG DESIGN; DRUG STABILITY; ENZYME INHIBITORS; HUMANS; INDIUM RADIOISOTOPES; MATRIX METALLOPROTEINASES; NEOPLASM PROTEINS; PENTETIC ACID; PEPTIDE MAPPING; PROTEIN BINDING; RADIOPHARMACEUTICALS; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 0034747364     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc010028f     Document Type: Article

References (26)

1. Clinical studies with matrix metalloproteinase inhibitors
2. Matrix metalloproteinases in cancer: Prognostic markers and targets for therapy
3. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor
4. Matrix metalloproteinases, a target for tumour imaging: In vivo evaluation of radiolabeled N-TIMP2
5. Radiolabeled monoclonal-antibodies - Radiochemical pharmacokinetic and clinical challenges
6. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4
7. Reactive site-modified tissue inhibitor of metalloproteinases-2 inhibits the cell-mediated activation of progelatinase A
8. Radiochemistry of DTPA-coupled monoclonal-antibodies
9. Kinetic analysis of the mechanism of interaction of full-length TIMP-2 and gelatinase A: Evidence for the existence of a low-affinity intermediate
10. A novel coumarin-labeled peptide for sensitive assays of matrix metalloproteinases
11. Coupling of DTPA to proteins - A critical analysis of the cyclic dianhydride method in the case of insulin modification
12. Human fibroblast stromelysin catalytic domain: Expression, purification, and characterization of a C-terminally truncated form
13. The N-terminal domain of tissue inhibitor metalloproteinases retains metalloproteinase inhibitory activity
14. Tissue Inhibitors of Matrix Metalloendopeptideases
15. High-resolution structure of the N-terminal domain of tissue inhibitor of metalloproteinases-2 and characterization of its interaction site with matrix metalloproteinase-3
16. Albumin labeled with Gd-DTPA - An intravascular contrast-enhancing agent for magnetic-resonance blood pool imaging - Preparation and characterization
17. Rabbit bone collagenase inhibitor blocks the activity of other neutral metalloproteinases
18. Tissue Inhibitor Of Metalloproteinase (TIMP-2) - A new member of the metalloproteinase inhibitor family
19. Matrix metalloproteinases and tumour invasion: From correlation and causality to the clinic
20. Structure and expression in breast-tumors of human TIMP-3, a new member of the metalloproteinase inhibitor family
21. Emerging therapeutic advances for the development of second generation matrix metalloproteinase inhibitors
22. Disulfide bond assignment in human tissue inhibitor of metalloproteinases (TIMP)
23. Solution structure of the active domain of tissue inhibitor of metalloproteinase-2. A new member of the OB fold protein family
24. Chemically and conformationally authentic active domain of human tissue inhibitor of metalloproteinases-2 refolded from bacterial inclusion bodies
25. Mapping the binding site for matrix metalloproteinase on the N-terminal domain of the tissue inhibitor of metalloproteinases-2 by NMR chemical shift perturbation
26. The effect of matrix metalloproteinase complex formation on the conformational mobility of tissue inhibitor of metalloproteinases-2 (TIMP-2)